Categories Science

The Empire Forum: Bringing Together Retina Science, Industry, and Investment

The Empire Forum: A New Gathering for Retina Specialists

Overview

This November, The Empire Forum will convene retina specialists, drug developers, and investors for a unique discussion on emerging therapies and their integration into clinical practice.

By combining pipeline updates with insights on financing and commercialization, the event aims to enlighten clinicians about ongoing treatments’ development and the related challenges in adopting them for patient care.

Event Details

  • Date: Thursday, Nov. 5, 12 PM – 8 PM EST
  • Location: Sheraton Times Square, New York City
  • Note: This event precedes the OSN New York & Retina conference, hosted at the same venue. Eyes On Eyecare will serve as the Forum’s official media partner.

Meeting Agenda

Designed for interaction among retina specialists, biotech/pharma executives, and healthcare investors, the one-day meeting emphasizes:

  • Late-stage development
  • The latest scientific findings
  • Commercialization challenges and opportunities

    Clinical Focus Areas

    The forum will feature sections dedicated to:

  • Geographic Atrophy (GA): Exploration of complement inhibition, neuroprotection, mitochondrial therapies, and ongoing phase 2 and 3 studies.
  • Wet Age-Related Macular Degeneration (AMD): Discussion on sustained delivery mechanisms, gene therapies, and innovations in targeting the VEGF pathway.
  • Diabetic Macular Edema (DME): Focus on extended-duration treatments, combination therapies, and novel biologics.
  • Rare and Inherited Retinal Diseases: Insights into gene replacement, gene editing, cell therapies, and considerations for commercialization.

Investment Insights

A specialized section will examine:

  • Strategies for funding retinal innovations
  • Mergers and acquisitions
  • Partnering opportunities and investor evaluations

Leadership

The forum is co-chaired by:

  • Rishi P. Singh, MD, FASRS
  • David Eichenbaum, MD, FASRS

Both leaders emphasize blending discussions of scientific advancements with considerations of patient care, commercialization, and the overall treatment burden.

Presentation Format

Expect a dynamic format featuring:

  • 7-minute podium presentations
  • 3-minute Q&A sessions
  • Moderated panels and expert commentary
  • Investor insights

Scientific programming will run from noon to 7 PM EST, followed by a networking reception from 7 to 8 PM EST.

Registration Information

  • Advance Registration: $100 (available through Sept. 30, 2026)
  • On-site Registration: $200 (pending space availability)

For registration, click here.

Editor’s Note

Stay tuned for ongoing coverage of The Empire Forum as the event approaches!

Leave a Reply

您的邮箱地址不会被公开。 必填项已用 * 标注

You May Also Like